---
title: "NMTC: Q3 FY2026 delivered 16% revenue growth, 59.9% gross margin, and key milestones for global expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295809067.md"
description: "Q3 FY2026 saw 16% revenue growth and 43% order growth, with gross margins rising to 59.9%. ISO 13485 certification enables international expansion, while new product and clinical milestones support future growth. Cash stood at $2.0 million, with no debt.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T13:39:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295809067.md)
  - [en](https://longbridge.com/en/news/295809067.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295809067.md)
generator: "portal-rs"
---

# NMTC: Q3 FY2026 delivered 16% revenue growth, 59.9% gross margin, and key milestones for global expansion

Q3 FY2026 saw 16% revenue growth and 43% order growth, with gross margins rising to 59.9%. ISO 13485 certification enables international expansion, while new product and clinical milestones support future growth. Cash stood at $2.0 million, with no debt.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md)

## Related News & Research

- [NeuroOne Advances StereoCED Toward Human Clinical Studies](https://longbridge.com/en/news/297210429.md)
- [NeuroOne reports successful large-animal procedures using next-generation StereoCED platform](https://longbridge.com/en/news/297191400.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [AI Winners, Victims, and the One Stock to Sell Now](https://longbridge.com/en/news/297431483.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**